OraSure Technologies (OSUR) Price CAGR: History & Chart

OraSure Technologies, Inc.(OSUR)

Medical - Instruments & Supplies · Bethlehem, PA

$3.81-0.31 (-7.42%)

Delayed quote: Oct 6, 2026, 3:05 PM EDT

About OraSure Technologies, Inc.

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions). It also provides several OraQuick rapid tests, encompassing solutions for HIV (Rapid, In-Home, and Self-Test versions), Hepatitis C (HCV rapid antibody), and Ebola (rapid antigen). Further diagnostic tools include the OraSure oral fluid collection device, utilized for HIV-1 antibody screening and confirmation; the Intercept drug testing systems; various immunoassay tests and reagents; and the Q.E.D. saliva alcohol test. Within its Molecular Solutions segment, OraSure offers an array of genomic products, notably under the Oragene and ORAcollect brand names, alongside specialized microbiome collection solutions and comprehensive GenoFIND genomics laboratory services. The company also supplies collection devices like ORAcollect, RNA, OMNIgene, and RAL, specifically designed for COVID-19 molecular testing. Another key offering is the Colli-Pee device, engineered for the precise volumetric collection of first-void urine. Furthermore, OraSure produces and distributes advanced kits for the collection, stabilization, transportation, and storage of genetic material samples, critical for molecular testing in diverse fields such as academic research, commercial applications (including ancestry, disease risk management, lifestyle analysis), and animal testing. Complementing these, it also provides various other diagnostic tools, including immunoassays and in vitro diagnostic tests. OraSure's sophisticated products and services are distributed to a wide array of clients, including clinical laboratories, hospitals, clinics, various community and public health organizations, wholesale distributors, governmental bodies, medical practices, and a broad spectrum of commercial and industrial entities. Established in 2000, OraSure Technologies, Inc. maintains its corporate headquarters in Bethlehem, Pennsylvania.

Bethlehem, PA

500 employees

www.orasure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Carrie Eglinton Manner

View full financials

Year	Start Price	End Price	Change	% Change
2026 (YTD)	$2.42	$4.11	+$1.69	+69.83%
2025	$3.61	$2.42	−$1.19	-32.96%
2024	$8.2	$3.61	−$4.59	-55.98%
2023	$4.82	$8.2	+$3.38	+70.12%
2022	$8.69	$4.82	−$3.87	-44.53%
2021	$10.59	$8.69	−$1.9	-17.90%
2020	$8.03	$10.59	+$2.56	+31.82%
2019	$11.68	$8.03	−$3.65	-31.25%
2018	$18.86	$11.68	−$7.18	-38.07%
2017	$8.78	$18.86	+$10.08	+114.81%
2016	$6.44	$8.78	+$2.34	+36.34%
2015	$10.14	$6.44	−$3.7	-36.49%
2014	$6.29	$10.14	+$3.85	+61.21%
2013	$7.18	$6.29	−$0.89	-12.40%
2012	$9.11	$7.18	−$1.93	-21.19%
2011	$5.75	$9.11	+$3.36	+58.43%
2010	$5.08	$5.75	+$0.67	+13.19%
2009	$3.68	$5.08	+$1.4	+38.04%
2008	$8.89	$3.68	−$5.21	-58.61%
2007	$8.26	$8.89	+$0.63	+7.63%
2006	$8.82	$8.26	−$0.56	-6.35%
2005	$6.72	$8.82	+$2.1	+31.25%
2004	$7.96	$6.72	−$1.24	-15.58%
2003	$5.45	$7.96	+$2.51	+46.06%
2002	$12.15	$5.45	−$6.7	-55.14%
2001	$8.25	$12.15	+$3.9	+47.27%
2000	$6.5	$8.25	+$1.75	+26.92%
1999	$5.88	$6.5	+$0.63	+10.64%
1998	$5	$5.88	+$0.88	+17.50%
1997	$11.5	$5	−$6.5	-56.52%

Year

Start Price

End Price

Change

% Change

2026 (YTD)

$2.42

$4.11

+$1.69

+69.83%

2025

$3.61

$2.42

−$1.19

-32.96%

2024

$8.2

$3.61

−$4.59

-55.98%

2023

$4.82

$8.2

+$3.38

+70.12%

2022

$8.69

$4.82

−$3.87

-44.53%

2021

$10.59

$8.69

−$1.9

-17.90%

2020

$8.03

$10.59

+$2.56

+31.82%

2019

$11.68

$8.03

−$3.65

-31.25%

2018

$18.86

$11.68

−$7.18

-38.07%

2017

$8.78

$18.86

+$10.08

+114.81%

2016

$6.44

$8.78

+$2.34

+36.34%

2015

$10.14

$6.44

−$3.7

-36.49%

2014

$6.29

$10.14

+$3.85

+61.21%

2013

$7.18

$6.29

−$0.89

-12.40%

2012

$9.11

$7.18

−$1.93

-21.19%

2011

$5.75

$9.11

+$3.36

+58.43%

2010

$5.08

$5.75

+$0.67

+13.19%

2009

$3.68

$5.08

+$1.4

+38.04%

2008

$8.89

$3.68

−$5.21

-58.61%

2007

$8.26

$8.89

+$0.63

+7.63%

2006

$8.82

$8.26

−$0.56

-6.35%

2005

$6.72

$8.82

+$2.1

+31.25%

2004

$7.96

$6.72

−$1.24

-15.58%

2003

$5.45

$7.96

+$2.51

+46.06%

2002

$12.15

$5.45

−$6.7

-55.14%

2001

$8.25

$12.15

+$3.9

+47.27%

2000

$6.5

$8.25

+$1.75

+26.92%

1999

$5.88

$6.5

+$0.63

+10.64%

1998

$5.88

+$0.88

+17.50%

1997

$11.5

−$6.5

-56.52%

Period	Period End	Value	QoQ Return	YoY Return
Q4 2026 (QTD)	2026-10-05	$4.11	+3.0%	+69.8%
Q3 2026	2026-09-22	$3.99	-4.1%	+25.1%
Q2 2026	2026-06-22	$4.16	+38.7%	+44.9%
Q1 2026	2026-03-31	$3.00	+24.0%	-18.0%
Q4 2025	2025-12-26	$2.42	-24.1%	-32.4%
Q3 2025	2025-09-25	$3.19	+11.1%	-25.6%

Period

Period End

Value

QoQ Return

YoY Return

Q4 2026 (QTD)

2026-10-05

$4.11

+3.0%

+69.8%

Q3 2026

2026-09-22

$3.99

-4.1%

+25.1%

Q2 2026

2026-06-22

$4.16

+38.7%

+44.9%

Q1 2026

2026-03-31

$3.00

+24.0%

-18.0%

Q4 2025

2025-12-26

$2.42

-24.1%

-32.4%

Q3 2025

2025-09-25

$3.19

+11.1%

-25.6%

Price CAGR: -6.51% (10Y, annualized)

OSUR Price CAGR Chart

OSUR Quarterly Price (YoY)

OSUR Quarterly Price

OSUR P/E Ratio

OSUR P/E Ratio Chart

OSUR Price CAGR History

Quarterly Price: QoQ & YoY

OSUR Earnings Yield

OSUR Earnings Yield Chart